Proteomics profiling reveals a distinct high-risk molecular subtype of hypertrophic cardiomyopathy

Abstract excerpt

OBJECTIVE: Hypertrophic cardiomyopathy (HCM) is a heterogeneous disease, likely encompassing several subtypes of disease with distinct biological mechanisms (ie, molecular subtypes). Current models based solely on clinical data have yielded limited accuracy in predicting the risk of major adverse cardiovascular events (MACE). Our aim in this study was to derive molecular subtypes in our multicentre prospective...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Advanced Proteomics Techniques and Applications
• Share to Cardiac Fibrosis and Remodeling
• Share to Cardiomyopathy and Myosin Studies